HBM Healthcare Investments invests USD 15.3 million in ADARx IPO, lifts stake to 1.2%
Bitget2026/09/28 04:45- HBM Healthcare Investments invested USD 15.3 million in ADARx Pharmaceuticals’ IPO, lifting total investment to USD 19.3 million.
- ADARx priced the offering at USD 17.00 per share, issuing 26,250,000 new shares for USD 446.25 million gross proceeds.
- Post-IPO stake rose to about 1.2%, valued at USD 25.4 million based on the first-day closing price.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Synopsys (SNPS.US) partners with OpenAI to develop AI models for chip design, revenue-sharing model drives stock price up by 7%
On Wednesday, chip design software provider Synopsys (SNPS.US) announced that it has reached a partnership agreement with OpenAI. Both parties will jointly develop AI models for the chip business and share related revenues.
BoJ Summary of Opinions: Member says appropriate to keep raising rates in line with economy, price
Rio Tinto secures Bell Bay aluminum smelter operations till 2031
The British Pound rallies on a UK growth upgrade and gives more than half back
Crypto prices
More
